# A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

> clinical trial · VERIFIED · 2026-08-03

Status: RECRUITING · Sponsor: Verastem, Inc. · Condition: Pancreatic Ductal Adenocarcinoma (PDAC)

- Company: Verastem, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07644559

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.